LA JOLLA, Calif., Jan. 29, 2008 (PRIME NEWSWIRE) -- Duska Therapeutics, Inc., (OTCBB:DSKA), a biopharmaceutical company developing diagnostic and therapeutic products based on adenosine 5'-triphosphate (ATP) and P2 receptor-related technologies, announced today that it has relocated its corporate offices from Bala Cynwd, Pennsylvania, to La Jolla, California. Duska’s new address is 470 Nautilus Street, Suite 300, La Jolla, CA, 92037. The company’s new telephone is (858) 551-5700.
